Doc.com

Doc.com Pursues Nasdaq Listing to Support Global Growth of AI Healthcare Platform

Doc.com Files for Nasdaq Listing as It Advances Global Expansion of Its AI-Powered, Blockchain-Secured Healthcare Platform Doc.com Inc., a pioneering healthcare technology company dedicated to democratizing access to quality healthcare, today announced that it has submitted an application for a proposed…

Read MoreDoc.com Pursues Nasdaq Listing to Support Global Growth of AI Healthcare Platform
Cinnamon

GHOST®, Cinnamon Toast Crunch™ and Lucky Charms™ Collaborate to Launch Protein-Fortified Cereals

GHOST®, Cinnamon Toast Crunch™ and Lucky Charms™ Team Up to Deliver Protein-Packed Cereals Get ready to level up your breakfast game! General Mills, in continued collaboration with lifestyle and sports nutrition brand GHOST®, is thrilled to announce the launch of two new crave-worthy,…

Read MoreGHOST®, Cinnamon Toast Crunch™ and Lucky Charms™ Collaborate to Launch Protein-Fortified Cereals
SynGenSys

SynGenSys Unveils Liver.SET Library to Enable Targeted Liver Gene Expression for In Vivo Therapies

SynGenSys Introduces Liver.SET Synthetic Promoter Library for Liver-specific Gene Expression for in vivo Gene Therapies SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch…

Read MoreSynGenSys Unveils Liver.SET Library to Enable Targeted Liver Gene Expression for In Vivo Therapies
Fujirebio

Fujirebio and Sysmex Launch Sales Partnership to Expand Dementia Testing Solutions

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and…

Read MoreFujirebio and Sysmex Launch Sales Partnership to Expand Dementia Testing Solutions
Approves

China’s NMPA Approves Promega’s MSI Detection Kit as a Companion Diagnostic for KEYTRUDA®

China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA® The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China. It is intended for use…

Read MoreChina’s NMPA Approves Promega’s MSI Detection Kit as a Companion Diagnostic for KEYTRUDA®
Americans

New Report Finds Americans Are Experiencing Illness More Frequently and at Younger Ages

New Report Reveals Americans Are Getting Sick More Often, Earlier in Life UnitedHealthcare and Health Action Council (HAC), a nonprofit employer coalition, today released their ninth annual white paper highlighting emerging health trends linked to workforce health and affordability. Based…

Read MoreNew Report Finds Americans Are Experiencing Illness More Frequently and at Younger Ages
Leyden

Leyden Labs Shows Feasibility of a Novel Antibody-Based Nasal Spray for Influenza Prevention

Leyden Labs Demonstrates Feasibility of Novel Antibody-Based Nasal Spray for Flu Prevention Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced landmark preclinical and clinical data in Science Translational Medicine supporting the development of their antibody-based nasal sprays to prevent influenza infection…

Read MoreLeyden Labs Shows Feasibility of a Novel Antibody-Based Nasal Spray for Influenza Prevention
Federal Court

Federal Court Issues Preliminary Injunction in Favor of WHOOP Against Lexqi

Federal Court Grants WHOOP Preliminary Injunction Against Lexqi WHOOP, the human performance company, today announced that the U.S. District Court for the District of Massachusetts has granted a motion by WHOOP for a preliminary injunction against Shenzhen Lexqi Electronic Technology Co.,…

Read MoreFederal Court Issues Preliminary Injunction in Favor of WHOOP Against Lexqi
Synthpop

Synthpop Secures $15 Million Series A Funding to Expand AI Focused on Humanizing Healthcare

Synthpop Raises $15 Million Series A to Scale AI That Makes Healthcare More Human Synthpop, Inc., a healthcare AI company building agentic automation to eliminate administrative bottlenecks in payer, provider, and patient operations, announced today a $15 million Series A,…

Read MoreSynthpop Secures $15 Million Series A Funding to Expand AI Focused on Humanizing Healthcare